Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.5.2 (
NQO1
)
6,196
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
2-Amino-3-carboxy-1,4-naphthoquinone, discovered as a novel bifidogenetic growth stimulator (BGS), has been characterized by determination of redox and acid-base equilibria, partition properties, and UV-vis and electron spin resonance spectral properties. BGS is proposed to function as an electron transfer mediator from NADH to O2. BGS is reduced by NADH-reduced
diaphorase
(or related enzymes) and the reduced BGS is reoxidized by autoxidation and a peroxidase-catalyzed reaction. The proposed reaction would spare pyruvate as an important metabolic intermediate, and minimize the cytotoxic effects of H2O2 generated by the autoxidation. Kinetic studies were performed in model enzymatic systems using 2-methyl-1,4-naphthoquinone (
VK3
) as a reference compound with a very weak growth-stimulating effect. The results support our proposal and reveal the superiority of BGS to
VK3
as an electron transfer mediator in the proposed reactions.
...
PMID:Mechanistic study on the roles of a bifidogenetic growth stimulator based on physicochemical characterization. 983 15